Paraiso, Jonny R.

HRN: 28-60-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/26/2026
04/01/2026
IV
500mg
Q12
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: